Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Significance Statement We propose a novel mechanism underlying loss of renal filtration function from studying glomerular endothelial cell (GEnC) fenestrae in human diabetic kidney tissue and in a mouse model of diabetes. Diaphragmed fenestrae may provide structural resistance to filtration. We hypothesize that EHD3 is a key regulator of GEnC fenestrations, and its glomerular expression is lost in diabetes. This study establishes the critical role of GEnC fenestrations in renal filtration function and suggests a key regulator, potentially paving the way for development of targeted therapies to restore fenestrae and thus filtration function in kidney disease. Background Glomerular endothelial cell (GEnC) fenestrations are recognized as an essential component of the glomerular filtration barrier, yet little is known about how they are regulated and their role in disease. Methods We comprehensively characterized GEnC fenestral and functional renal filtration changes including measurement of glomerular K f and GFR in diabetic mice (BTBR ob−/ob− ). We also examined and compared human samples. We evaluated Eps homology domain protein-3 (EHD3) and its association with GEnC fenestrations in diabetes in disease samples and further explored its role as a potential regulator of fenestrations in an in vitro model of fenestration formation using b.End5 cells. Results Loss of GEnC fenestration density was associated with decreased filtration function in diabetic nephropathy. We identified increased diaphragmed fenestrations in diabetes, which are posited to increase resistance to filtration and further contribute to decreased GFR. We identified decreased glomerular EHD3 expression in diabetes, which was significantly correlated with decreased fenestration density. Reduced fenestrations in EHD3 knockdown b.End5 cells in vitro further suggested a mechanistic role for EHD3 in fenestration formation. Conclusions This study demonstrates the critical role of GEnC fenestrations in renal filtration function and suggests EHD3 may be a key regulator, loss of which may contribute to declining glomerular filtration function through aberrant GEnC fenestration regulation. This points to EHD3 as a novel therapeutic target to restore filtration function in disease.

Original publication

DOI

10.1681/asn.2021030294

Type

Journal article

Journal

Journal of the American Society of Nephrology

Publisher

Ovid Technologies (Wolters Kluwer Health)

Publication Date

06/2022

Volume

33

Pages

1120 - 1136